Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
$26.98
+2.1%
$27.24
$23.31
$29.61
$13.49M1.031,122 shs1,425 shs
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
$21.08
+0.1%
$21.35
$20.58
$22.50
$225.56M0.0660,549 shs24,640 shs
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
C$0.06
C$0.02
C$0.12
C$14.59MN/A698,779 shs8.14 million shs
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$0.16
$0.20
$3.30
$419K1.23.04 million shs16,105 shs
UTME
UTime
$0.24
$0.25
$0.40
$3.40
$3.24M0.29642,635 shs70,825 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
+0.80%+1.69%-4.50%+4.71%-1.16%
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
+0.07%+0.02%-2.09%-2.68%-4.66%
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
0.00%0.00%0.00%0.00%0.00%
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
0.00%0.00%0.00%0.00%0.00%
UTME
UTime
0.00%-13.94%+11.11%+6.47%-68.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
N/AN/AN/AN/AN/AN/AN/AN/A
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
UTME
UTime
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
0.00
N/AN/AN/A
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
0.00
N/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/A
UTME
UTime
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
N/AN/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$146.07M0.00N/AN/A($14.77) per share0.00
UTME
UTime
$200.55M0.02N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
N/AN/A8.29N/AN/AN/AN/AN/A
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
-$77.14MN/A0.00N/AN/A-59.70%N/A-37.01%N/A
UTME
UTime
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
$0.702.59%N/AN/AN/A
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
$0.783.70%N/AN/AN/A
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
N/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/A
UTME
UTime
N/AN/AN/AN/AN/A

Latest UTME, ICP, PTX, FPA, and IBTJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/28/2024
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
Monthly$0.07174/1/20244/2/20244/5/2024
3/20/2024
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
$0.11813/21/20243/22/20243/28/2024
2/29/2024
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
Monthly$0.06383/1/20243/4/20243/7/2024
1/31/2024
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
Monthly$0.07262/1/20242/2/20242/7/2024
(Data available from 1/1/2013 forward)

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
First Trust Asia Pacific ex-Japan AlphaDEX Fund stock logo
FPA
First Trust Asia Pacific ex-Japan AlphaDEX Fund
147,000500,002N/ANot Optionable
iShares iBonds Dec 2029 Term Treasury ETF stock logo
IBTJ
iShares iBonds Dec 2029 Term Treasury ETF
147,00010.70 millionN/ANot Optionable
Belgravia Capital International Inc, stock logo
ICP
Belgravia Capital International Inc,
147,000243.24 millionN/ANot Optionable
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/A14.51 millionN/AOptionable
UTME
UTime
26213.57 million6.15 millionNot Optionable

UTME, ICP, PTX, FPA, and IBTJ Headlines

SourceHeadline
2024 UTME: My Counsel for The Next Jambites2024 UTME: My Counsel for The Next Jambites
thisdaylive.com - April 23 at 5:07 PM
UTIME LTD: UTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleUTIME LTD: UTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
finanznachrichten.de - March 5 at 9:52 AM
UTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleUTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
globenewswire.com - March 4 at 9:00 PM
UTME: JAMB Denies Increment in Exam Registration FeeUTME: JAMB Denies Increment in Exam Registration Fee
thisdaylive.com - December 30 at 10:13 AM
2024 UTME: JAMB Announces Dates for Sales, Registration, Exams2024 UTME: JAMB Announces Dates for Sales, Registration, Exams
thisdaylive.com - December 2 at 1:30 PM
UTime Ltd WTOUTime Ltd WTO
morningstar.com - November 19 at 3:18 PM
UTime Limited (WTO)UTime Limited (WTO)
ca.finance.yahoo.com - September 20 at 9:10 AM
UTime Limited Announces Nasdaq Ticker Symbol Change to WTOUTime Limited Announces Nasdaq Ticker Symbol Change to WTO
finance.yahoo.com - August 28 at 3:17 PM
UTime LimitedUTime Limited
thestreet.com - August 23 at 6:16 PM
UTime Limited’s latest rating changes from various analystsUTime Limited’s latest rating changes from various analysts
knoxdaily.com - July 19 at 6:33 PM
UTME - UTime LimitedUTME - UTime Limited
finance.yahoo.com - July 15 at 12:35 AM
Analyzing UTime Limited (UTME) After Recent Trading ActivityAnalyzing UTime Limited (UTME) After Recent Trading Activity
knoxdaily.com - July 12 at 2:50 PM
2023 UTME: Mmesoma confirms she forged JAMB result2023 UTME: Mmesoma confirms she forged JAMB result
premiumtimesng.com - July 12 at 9:50 AM
FLASHBACK: Five times JAMB caught candidates who falsified their UTME resultsFLASHBACK: Five times JAMB caught candidates who falsified their UTME results
premiumtimesng.com - July 9 at 7:13 PM
UTime Limited (UTME) stock historical prices & data – Yahoo FinanceUTime Limited (UTME) stock historical prices & data – Yahoo Finance
sg.finance.yahoo.com - June 21 at 7:05 PM
UTime Shares Halted On Circuit Breaker To The UpsideUTime Shares Halted On Circuit Breaker To The Upside
benzinga.com - June 15 at 5:43 PM
UTime Ltd.UTime Ltd.
barrons.com - June 8 at 4:39 AM
Fewer Investors Than Expected Jumping On UTime Limited (NASDAQ:UTME)Fewer Investors Than Expected Jumping On UTime Limited (NASDAQ:UTME)
finance.yahoo.com - April 19 at 6:25 PM
JAMB Reschedules Timetable for 2023 UTME, to Hold Mock-UTME April 18JAMB Reschedules Timetable for 2023 UTME, to Hold Mock-UTME April 18
thisdaylive.com - April 13 at 10:51 AM
UTime Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyUTime Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finance.yahoo.com - March 30 at 5:34 PM
Mock-UTME notification slips ready, JAMB tells candidatesMock-UTME notification slips ready, JAMB tells candidates
sunnewsonline.com - March 29 at 3:57 PM
UTME Mock: 176,408 Candidates to Sit for ExamsUTME Mock: 176,408 Candidates to Sit for Exams
thisdaylive.com - March 29 at 3:57 PM
UTIME LTD: UTime Announces Financial Results for The First Six Months of Fiscal Year 2023UTIME LTD: UTime Announces Financial Results for The First Six Months of Fiscal Year 2023
finanznachrichten.de - March 24 at 2:00 PM
UTime Announces Financial Results for The First Six Months of Fiscal Year 2023UTime Announces Financial Results for The First Six Months of Fiscal Year 2023
finance.yahoo.com - March 24 at 2:00 PM

Media Sentiment Over Time

Company Descriptions

First Trust Asia Pacific ex-Japan AlphaDEX Fund logo

First Trust Asia Pacific ex-Japan AlphaDEX Fund

NASDAQ:FPA
The First Trust Asia Pacific Ex-Japan AlphaDEX Fund (FPA) is an exchange-traded fund that mostly invests in total market equity. The fund selects and weights 100 stocks from the S&P Asia Pacific Ex-Japan BMI Index based on their growth and value factors. FPA was launched on Apr 18, 2011 and is managed by First Trust.
iShares iBonds Dec 2029 Term Treasury ETF logo

iShares iBonds Dec 2029 Term Treasury ETF

NASDAQ:IBTJ
The iShares iBonds Dec 2029 Term Treasury ETF (IBTJ) is an exchange-traded fund that is based on the ICE 2029 Maturity US Treasury index. The fund tracks a market-value-weighted index of US Treasury bonds maturing between January and December 2029. The fund will terminate in December 2029. IBTJ was launched on Feb 25, 2020 and is managed by BlackRock.
Belgravia Capital International Inc, logo

Belgravia Capital International Inc,

TSE:ICP
Belgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.
Pernix Therapeutics logo

Pernix Therapeutics

NASDAQ:PTX
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.

UTime

NASDAQ:UTME
UTime Limited, together with its subsidiaries, designs, develops, manufactures, sells, and operates mobile phones, accessories, and related consumer electronics. The company offers consumer electronics, such as power banks, bluetooth speakers, batteries, chargers, cell phone parts, molds, and shells. It provides electronics manufacturing services, including original equipment manufacturer and original design manufacturer services. It sells its products under the UTime and Do brand names in South America, South Asia, Southeast Asia, and Africa. UTime Limited was founded in 2008 and is headquartered in Shenzhen, China.